Charm Therapeutics
Building Leadership Confidence by Recruiting a Chairman to Mentor a First-Time CEO and Signal Strength to Investors
Charm harnesses the power of deep learning on 3D molecular configurations to deliver medicines of transformational efficacy to patients. To support Charm’s mission we strategically recruited a seasoned Chairman to mentor a first-time CEO and strengthen leadership confidence. This move not only accelerated executive development but also signaled credibility and stability to investors at a critical stage of growth.
THE CHALLENGE
As a first-time founder, Charm’s CEO Laksh Aithani needed strategic decision support while establishing strong, credible signals to prospective investors.This individual would tangibly serve as a mentor to a youthful first time CEO, but also transmit powerful optics to potential investors.
THE SOLUTION
Occam delivered a compelling solution in Gary Glick. Glick, President and CEO of Odyssey Therapeutics, is a formidable chemist and serial biotech entrepreneur in his own right.
Glick has founded several successful companies, including Scorpion and IFM Therapeutics. While CEO of IFM, the company progressed three programs from ideation to clinical development and executed several major deals, including the sale of oncology assets to Bristol-Myers Squibb in a transaction valued more than $2.5B.
This case study demonstrates how strategic life science executive search and recruitment transform life science companies in their pursuit of technological innovation. Furthermore, it highlights Occam Global's critical role in propelling Charms's evolution from a startup to a disruptive force in the techbio industry.
Contact us today to build your life science executive team and define your next strategic move.
.jpg)
THE IMPACT
High-Impact Leadership Signal:
Glick added both deep expertise and high-profile credibility, elevating Charm’s leadership presence at a pivotal growth stage.
Catalyzing Investor Confidence:
Glick’s recruitment played a key role in positioning Laksh to successfully close a $50M Series A with top-tier investors including F-Prime and OrbiMed.
FROM THE CLIENT
“
Occam played a pivotal role in the build of CHARM Therapeutics with the critical placement of our Executive Chairman, Gary Glick.
”
Laksh Aithani
Founder & CEO CHARM Therapeutics
IN SUMMARY
We were proud to play a pivotal role in advancing Charm Therapeutics from an emerging startup to a disruptive force in techbio. Our strategic approach to biotech executive search and recruitment helps accelerate your company’s path to meaningful technological innovation.
CONTACT US TO HELP BUILD YOUR LIFE SCIENCE EXECUTIVE TEAM.
FAQ
LEARN MORE ABOUT OUR DISTINCTIVE APPROACH
Does AI threaten executive search careers?
Less than most professions. AI can assist with sourcing and data, but the core of the work — building trust, navigating conflicting stakeholders, and judging how a leader will perform in a specific context — depends on human capabilities AI does not have. This makes the work relatively resilient to automation.
Can a new graduate go into executive search directly, without consulting first?
There’s no single required path. Strong analytical training, clear writing, comfort with ambiguity, and genuine curiosity about people are the real common denominators. Having an MBA is frequently valued because the underlying skills transfer directly but the traits matter more than any one credential.
How is executive search different from recruiting?
High-level executive search is strategic advisory work focused on leadership selection at pivotal moments, placing CEOs, executives, and board members, and advising founders and boards. It involves far more judgment, psychology, and strategic counsel than transactional recruiting, which centers on filling roles against a specification.
